Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Med Tech-related technology assessments and clinical guidelines from NICE in the second half of February 2018

Interventional Procedure Guidance is developed for most of the novel interventional procedures entering the English market. The program focuses solely on the clinical evidence. Recommendations may vary from ‘for research only’ to ‘for use with standard arrangements for clinical governance, consent, and audit.' Recommendations are not binding, although they are followed by providers and commissioners.

In the second half of February NICE published the following new Interventional Procedure Guidance:

Medical technologies guidance evaluates new, innovative medical devices and diagnostics. In the first half of February NICE published one new Medical Technologies Guidance Peristeen transanal irrigation system for managing bowel dysfunction. The case for adopting Peristeen for transanal irrigation in people with bowel dysfunction is supported by the evidence. Peristeen may not be suitable for all people with bowel dysfunction. It may take several weeks before a person is comfortable with using Peristeen, and some people may choose to stop using it. Cost modelling for Peristeen is uncertain, but it is likely that Peristeen provides additional clinical benefits without costing more than standard bowel care.

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.